Sign In
Buy RDNT
$56.20
+0.440 (+0.789%)
At Close: Jun 23, 2026
Don't Overlook These Highly Ranked Medical Stocks as Markets Rise
05:01pm, Wednesday, 12'th Jun 2024
With earnings estimate revisions on the rise for these top medical stocks, they certainly shouldn't be overlooked given their blazing historical performances.
New Strong Buy Stocks for June 12th
05:55am, Wednesday, 12'th Jun 2024
RDNT, ESLT, CLS, LNTH and ASBFY have been added to the Zacks Rank #1 (Strong Buy) List on June 12, 2024.
5 Stocks to Gain as Service Side of the Economy Bounces Back
09:30am, Tuesday, 11'th Jun 2024
With service sector activity rebounding in recent times, it's worth placing bets on stocks such as CareCloud (CCLD), DaVita (DVA), RadNet (RDNT), SkyWest (SKYW) and American Express (AXP).
RadNet, Inc. to Present at the Sidoti & Company 2024 Small Cap Conference on Wednesday, June 12th
06:00am, Tuesday, 11'th Jun 2024
LOS ANGELES, June 11, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and
RadNet, Inc. to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024
06:00am, Friday, 07'th Jun 2024
LOS ANGELES, June 07, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and
RadNet, Inc. (RDNT) Hits Fresh High: Is There Still Room to Run?
10:15am, Thursday, 06'th Jun 2024
RadNet (RDNT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
3 Reasons Why Growth Investors Shouldn't Overlook RadNet (RDNT)
01:46pm, Wednesday, 05'th Jun 2024
RadNet (RDNT) could produce exceptional returns because of its solid growth attributes.
RadNet: Qualified Growth Route, Still Undervalued
08:03pm, Tuesday, 04'th Jun 2024
RadNet, Inc. shares continue to show strength, having compounded by 184% since 2022. Q1 FY 2024 earnings showed growth in the Digital Health segment and increased MRI, CT, and PET/CT volumes. Manageme
All You Need to Know About RadNet (RDNT) Rating Upgrade to Strong Buy
01:01pm, Tuesday, 04'th Jun 2024
RadNet (RDNT) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
RadNet, Inc. to Present at the Jefferies 2024 Global Healthcare Conference on June 5, 2024
06:00am, Monday, 03'rd Jun 2024
LOS ANGELES, June 03, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and
RadNet, Inc. to Present at the Bank of America Securities 2024 Health Care Conference on May 14th, 2024
06:00am, Monday, 13'th May 2024
LOS ANGELES, May 13, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and
RadNet, Inc. (RDNT) Q1 2024 Earnings Call Transcript
06:14pm, Thursday, 09'th May 2024
RadNet, Inc. (NASDAQ:RDNT ) Q1 2024 Results Conference Call May 9, 2024 10:30 AM ET Company Participants Mark Stolper - Executive Vice President & Chief Financial Officer Dr. Howard Berger - Chairman,
RadNet (RDNT) Q1 Earnings and Revenues Surpass Estimates
07:31pm, Wednesday, 08'th May 2024
RadNet (RDNT) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of a loss of $0.09 per share. This compares to loss of $0.08 per share a year ago.
LOS ANGELES, May 08, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a netw
RadNet (RDNT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
11:05am, Wednesday, 01'st May 2024
RadNet (RDNT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
